PHASE IIA: Trial of a Novel Ondansetron Formulation (OND-PR002) and Immediate-Release Methylphenidate (Ritalin®)(OND003IND)
This study is enrolling participants by invitation only.
Sponsor:
Tong Lee
Collaborators:
Information provided by (Responsible Party):
Tong Lee, Duke University Medical Center
ClinicalTrials.gov Identifier:
NCT01377662
First received: June 12, 2011
Last updated: October 15, 2012
Last verified: October 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is enrolling participants by invitation only. |
|---|---|
| Estimated Study Completion Date: | April 2013 |
| Estimated Primary Completion Date: | January 2013 (Final data collection date for primary outcome measure) |